MOVIN Enters India’s Healthcare Logistics Market With Temperature-Controlled Delivery Vertical

The new vertical is designed to address the fast-growing demand for secure, temperature-controlled movement of pharmaceutical, MedTech, diagnostics, and laboratory shipments.

MOVIN, the logistics brand formed through a joint venture between InterGlobe Enterprises and UPS, has announced its entry into India’s healthcare logistics sector with the launch of MOVIN Healthcare.

The new vertical is designed to address the fast-growing demand for secure, temperature-controlled movement of pharmaceutical, MedTech, diagnostics, and laboratory shipments.

India’s healthcare express logistics market, valued at $5.5–$7.5 billion, is expanding rapidly amid rising healthcare consumption and the need for reliable movement of sensitive medical materials. MOVIN Healthcare enters this segment with a specialised portfolio offering end-to-end packaging solutions capable of maintaining 2–8°C refrigerated, 15–25°C controlled ambient, and dry ice frozen (-80°C to -20°C) conditions. These capabilities are essential for vaccines, biologics, pharmaceuticals, and clinical trial materials.

All shipments under the new vertical will be equipped with real-time monitoring, supported by a 24/7 control tower to ensure visibility and secure transit. The vertical will also offer priority handling across the network and comprehensive carrier insurance for healthcare consignments.

A key component of the rollout is MOVIN Healthcare’s Next Flight Out (NFO) service, positioned for time-critical medical movements.

The service is structured to support urgent requirements for hospitals, laboratories and research organisations needing fast and controlled transportation.

MOVIN Healthcare will operate as a dedicated, resource-backed unit within MOVIN, staffed with trained personnel and customer service teams focused exclusively on healthcare logistics. Its operational framework includes specialised packaging solutions, handling of time-sensitive shipments, and stringent quality protocols.

The initial phase will cover 50 strategic markets, with a planned nationwide expansion based on demand patterns. The company aims to strengthen its presence across major healthcare hubs, diagnostics clusters, and pharmaceutical manufacturing zones as part of the wider rollout.

Stay tuned for more such updates on Digital Health News